Alembic Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	533573	NSE Symbol:	APLLTD	P/E :	29.05
ISIN Demat:	INE901L01018	Div & Yield %:	1.47	EPS :	25.82
Book Value:	267.35	Market Cap (Rs. Cr.):	14,745.18	Face Value :	2

Date	Headline
24-Feb-26	Alembic Pharma receives USFDA approval for Efinaconazole Topical Solution, 10%
06-Feb-26	Alembic Pharmaceuticals receives USFDA approval for Carbidopa, Levodopa and Entacapone Tablets
27-Jan-26	Alembic Pharmaceuticals receives USFDA approval for Durezol Ophthalmic Emulsion, 0.05%
20-Jan-26	Alembic Pharmaceuticals to declare Quarterly Results
12-Jan-26	Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib Tablets, 400 mg
18-Dec-25	Alembic receives USFDA approval for Travoprost Ophthalmic Solution
11-Dec-25	Alembic receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/
01-Dec-25	Alembic Pharmaceuticals announces change in senior management
15-Nov-25	Alembic Pharma receives USFDA approval for Diltiazem hydrochloride tablets
07-Nov-25	Alembic receives USFDA approval for Dasatinib Tablets

Company Snapshot